BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24407940)

  • 21. Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer.
    Yamashita Y; Bekki Y; Imai D; Ikegami T; Yoshizumi T; Ikeda T; Kawanaka H; Nishie A; Shirabe K; Maehara Y
    Thromb Res; 2014 Oct; 134(4):826-31. PubMed ID: 25156238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative complications in patients with portal vein thrombosis after liver transplantation: evaluation with Doppler ultrasonography.
    Jia YP; Lu Q; Gong S; Ma BY; Wen XR; Peng YL; Lin L; Chen HY; Qiu L; Luo Y
    World J Gastroenterol; 2007 Sep; 13(34):4636-40. PubMed ID: 17729421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portal vein thrombosis following elective laparoscopic splenectomy: incidence and analysis of risk factors.
    Swinson B; Waters PS; Webber L; Nathanson L; Cavallucci DJ; O'Rourke N; Bryant RD
    Surg Endosc; 2022 May; 36(5):3332-3339. PubMed ID: 34331132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism.
    Kawanaka H; Akahoshi T; Kinjo N; Konishi K; Yoshida D; Anegawa G; Yamaguchi S; Uehara H; Hashimoto N; Tsutsumi N; Tomikawa M; Maehara Y
    Ann Surg; 2010 Jan; 251(1):76-83. PubMed ID: 19864937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of potential portal vein thrombus during laparoscopic right hemihepatectomy following portal vein embolization.
    Kitano Y; Inoue Y; Sato Y; Oba A; Ono Y; Sato T; Ito H; Matsueda K; Baba H; Takahashi Y
    Langenbecks Arch Surg; 2024 Feb; 409(1):56. PubMed ID: 38332380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis.
    Li MX; Zhang XF; Liu ZW; Lv Y
    Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):512-9. PubMed ID: 24103282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative portomesenteric venous thrombosis: lessons learned from 1,069 consecutive laparoscopic colorectal resections.
    Allaix ME; Krane MK; Zoccali M; Umanskiy K; Hurst R; Fichera A
    World J Surg; 2014 Apr; 38(4):976-84. PubMed ID: 24240673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of portal and splenic vein thrombosis after laparoscopic splenectomy: a retrospective analysis of a single-center experience.
    Kuroki T; Kitasato A; Tokunaga T; Takeshita H; Taniguchi K; Maeda S; Fujioka H
    Surg Today; 2018 Aug; 48(8):804-809. PubMed ID: 29569060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.
    Rodriguez-Castro KI; Vitale A; Fadin M; Shalaby S; Zerbinati P; Sartori MT; Landi S; Pettinari I; Piscaglia F; Han G; Burra P; Simioni P; Senzolo M
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):34-42. PubMed ID: 30188408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplant recipients with portal vein thrombosis: a single center retrospective study.
    Tao YF; Teng F; Wang ZX; Guo WY; Shi XM; Wang GH; Ding GS; Fu ZR
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):34-9. PubMed ID: 19208512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation.
    Werner KT; Sando S; Carey EJ; Vargas HE; Byrne TJ; Douglas DD; Harrison ME; Rakela J; Aqel BA
    Dig Dis Sci; 2013 Jun; 58(6):1776-80. PubMed ID: 23314858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of portal vein thrombosis after splenectomy for patients with idiopathic portal hypertension.
    Hirashita T; Ohta M; Kai S; Masuda T; Eguchi H; Iwashita Y; Ogawa T; Kitano S
    Surg Today; 2011 Nov; 41(11):1475-80. PubMed ID: 21969148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study.
    am Esch JS; Schmelzle M; Fürst G; Robson SC; Krieg A; Duhme C; Tustas RY; Alexander A; Klein HM; Topp SA; Bode JG; Häussinger D; Eisenberger CF; Knoefel WT
    Ann Surg; 2012 Jan; 255(1):79-85. PubMed ID: 22156926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of acute post-operative portal venous thrombosis.
    Thomas RM; Ahmad SA
    J Gastrointest Surg; 2010 Mar; 14(3):570-7. PubMed ID: 19582513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
    Scheiner B; Stammet PR; Pokorny S; Bucsics T; Schwabl P; Brichta A; Thaler J; Lampichler K; Ba-Ssalamah A; Ay C; Ferlitsch A; Trauner M; Mandorfer M; Reiberger T
    Wien Klin Wochenschr; 2018 Jul; 130(13-14):446-455. PubMed ID: 29916054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.
    Kawanaka H; Akahoshi T; Itoh S; Iguchi T; Harimoto N; Uchiyama H; Yoshizumi T; Shirabe K; Takenaka K; Maehara Y
    J Am Coll Surg; 2014 Nov; 219(5):865-74. PubMed ID: 25256370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
    Hayashi T; Takatori H; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Kitamura K; Kawaguchi K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Toyama T; Okumura K; Kozaka K; Kaneko S
    BMC Gastroenterol; 2019 Dec; 19(1):217. PubMed ID: 31842768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up to 50% of portal vein thrombosis remains undiagnosed until liver transplantation.
    Bert J; Geerts A; Vanlander A; Abreu de Carvalho L; Degroote H; Berrevoet F; Rogiers X; van Vlierberghe H; Verhelst X
    Clin Transplant; 2020 Dec; 34(12):e14107. PubMed ID: 33030231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.